Affenpocken - Rapid Risk Assessment

Safety warnings | Blood & Tissue | 24/05/2022

The Federal Office for Safety in Health Care would like to draw attention to the current Rapid Risk Assessment of the ECDC (European Centre for Disease Prevention and Control) on monkeypox.

In summary:

All potential donors should be carefully interviewed regarding contacts with infected (confirmed or suspected) MPX cases, infected animals or travels to affected areas. Medical history data on these risk factors should be collected in the case of deceased donors.

Based on the incubation period of MPX, it is recommended to defer asymptomatic donors that have been in contact with (confirmed or suspected) cases from substances of human origin donation for a minimum of 21 days from the last day of exposure.

Since the MPX prodromal stage varies in duration (1–4 days) and symptoms can be non-specific and mild or absent, careful examination for any possible signs of infection should be performed even after the expiration of the deferral period (at least 21 days from the last day of exposure). Examination should not overlook mild and non-specific signs like headache or fatigue or anogenital skin lesions.

This letter reflects the current information available from BASG. As more information becomes available, it will be posted.


Further inquiry note